Quel potentiel de développement et quels consommateurs à l'international pour les vins rosés ? by Eymard B., Amato Brice, Delerins R.C.

Get full text

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era by Thompson, R, Abicht, A, Beeson, D, Engel, A, Eymard, B, Maxime, E, Lochmüller, H

Childhood-onset form of myotonic dystrophy type 1 and autism spectrum disorder: Is there comorbidity? by Angeard, N, Huerta, E, Jacquette, A, Cohen, D, Xavier, J, Gargiulo, M, Servais, L, Eymard, B, Héron, D

The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder by Muller, J, Burke, G, Cossins, J, Richard, P, Baumeister, S, Stucka, R, Eymard, B, Hantai, D, Beeson, D, Lochmuller, H, Abicht, A

The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder. by Müller, J, Abicht, A, Burke, G, Cossins, J, Richard, P, Baumeister, S, Stucka, R, Eymard, B, Hantaï, D, Beeson, D, Lochmüller, H

Long-term observational study of sporadic inclusion body myositis. by Benveniste, O, Guiguet, M, Freebody, J, Dubourg, O, Squier, W, Maisonobe, T, Stojkovic, T, Leite, M, Allenbach, Y, Herson, S, Brady, S, Eymard, B, Hilton-Jones, D

Long-term observational study of sporadic inclusion body myositis by Benveniste, O, Guiguet, M, Freebody, J, Dubourg, O, Squier, W, Maisonobe, T, Stojkovic, T, Leite, M, Allenbach, Y, Herson, S, Brady, S, Eymard, B, Hilton-Jones, D

Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins by Mamrut, S, Avidan, N, Truffault, F, Staun-Ram, E, Sharshar, T, Eymard, B, Frenkian, M, Pitha, J, de Baets, M, Servais, L, Berrih-Aknin, S, Miller, A

Hearing impairment in patients with myotonic dystrophy type 2 by van Vliet, J, Tieleman, AA, van Engelen, BGM, Bassez, G, Servais, L, Béhin, A, Stojkovic, T, Meulstee, J, Engel, JAM, Lamas, G, Eymard, B, Verhagen, WIM, Mamelle, E

Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1 by Bachasson, D, Moraux, A, Ollivier, G, Decostre, V, Ledoux, I, Gidaro, T, Servais, L, Behin, A, Stojkovic, T, Hébert, LJ, Puymirat, J, Eymard, B, Bassez, G, Hogrel, J-Y

Transcriptional control of CHRNA1 gene in thymus by a promoter SNP associated with onset of autoimmune myasthenia gravis. by Giraud, M, Toubert, R, Kyewski, B, Vandiedonck, C, Levi-Strauss, M, Pagani, F, Baralle, F, Eymard, B, Tranchant, C, Gajdos, P, Vincent, A, Willcox, N, Beeson, D, Garchon, H

An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. by Giraud, M, Taubert, R, Vandiedonck, C, Ke, X, Lévi-Strauss, M, Pagani, F, Baralle, F, Eymard, B, Tranchant, C, Gajdos, P, Vincent, A, Willcox, N, Beeson, D, Kyewski, B, Garchon, H

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC). by Ashizawa, T, Gonzales, I, Ohsawa, N, Singer, R, Devillers, M, Ashizawa, T, Balasubramanyam, A, Cooper, T, Khajavi, M, Lia-Baldini, A, Miller, G, Philips, A, Timchenko, LT, Waring, J, Yamagata, H, Barbet, J, Klesert, T, Tapscott, S, Roses, A, Wagner, M, Baiget, M, Martorell, L, Browne, G, Eymard, B, Gourdon, G

Impaired presynaptic high-affinity choline transporter causes a congenital myasthenic syndrome with episodic apnea by Bauché, S, O'Regan, S, Azuma, Y, Laffargue, F, McMacken, G, Sternberg, D, Brochier, G, Buon, C, Bouzidi, N, Topf, A, Lacène, E, Remerand, G, Beaufrere, A-M, Pebrel-Richard, C, Thevenon, J, El Chehadeh-Djebbar, S, Faivre, L, Duffourd, Y, Ricci, F, Mongini, T, Fiorillo, C, Astrea, G, Burloiu, CM, Butoianu, N, Sandu, C, Servais, L, Bonne, G, Nelson, I, Desguerre, I, Nougues, M-C, Bœuf, B, Romero, N, Laporte, J, Boland, A, Lechner, D, Deleuze, J-F, Fontaine, B, Strochlic, L, Lochmuller, H, Eymard, B, Mayer, M, Nicole, S